DISEASE STATE
Drug
GENZYME CORPORATION
Total Payments
$2.3M
Transactions
4,109
Doctors
2,230
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $1.1M | 1,848 | 1,131 |
| 2018 | $491,925 | 1,035 | 617 |
| 2017 | $659,046 | 1,226 | 735 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.9M | 910 | 84.3% |
| Food and Beverage | $260,867 | 2,907 | 11.6% |
| Travel and Lodging | $91,372 | 289 | 4.1% |
| Grant | $1,500 | 2 | 0.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $76.03 | 1 | 0.0% |
Top Doctors Receiving Payments for DISEASE STATE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Neurology | San Antonio, TX | $44,079 | 33 |
| , M.D | Nephrology | Norfolk, VA | $43,687 | 50 |
| , MD | Neurology | Houston, TX | $37,202 | 35 |
| , D.O | Neurology | Centerville, OH | $34,012 | 34 |
| , MD | Surgical Oncology | Los Angeles, CA | $28,286 | 19 |
| , M.D | Neurology | Palos Heights, IL | $28,184 | 25 |
| , D.O | Neurology | Bellevue, OH | $25,545 | 29 |
| Suhayl Dhib-Jalbut | Neurology | New Brunswick, NJ | $22,398 | 18 |
| , MD | Specialist | Hermitage, PA | $21,692 | 30 |
| , M.D | Neurology | Golden Valley, MN | $21,554 | 13 |
| , M.D | Neurology | Tampa, FL | $20,067 | 15 |
| , M.D | Pediatric Cardiology | Cincinnati, OH | $18,816 | 18 |
| , M.D | Neurology | Bellevue, OH | $18,293 | 15 |
| , MD | Neurology | Philadelphia, PA | $18,185 | 18 |
| , MD | Neurology | Orange, CA | $18,098 | 15 |
| , M.D | Pulmonary Disease | New York, NY | $16,764 | 14 |
| , M.D | Neurology | Cincinnati, OH | $16,348 | 12 |
| , M.D | Clinical Genetics (M.D.) | Philadelphia, PA | $16,087 | 15 |
| , MD | Neurology | Brookline, MA | $15,839 | 15 |
| , MD | Uveitis and Ocular Inflammatory Disease | Brandon, FL | $15,495 | 17 |
| , MD | Nuclear Medicine | Washington, DC | $15,369 | 12 |
| , MD | Hematology & Oncology | Las Vegas, NV | $15,073 | 10 |
| , M.D | Specialist | Houston, TX | $14,827 | 18 |
| , M.D | Neurology | Milwaukee, WI | $14,768 | 10 |
| , M.D | Neurology | Pittsburgh, PA | $14,649 | 27 |
Ad
Manufacturing Companies
- GENZYME CORPORATION $1.7M
- SANOFI-AVENTIS U.S. LLC $484,198
- SANOFI PASTEUR INC. $20,553
Product Information
- Type Drug
- Total Payments $2.3M
- Total Doctors 2,230
- Transactions 4,109
About DISEASE STATE
DISEASE STATE is a drug associated with $2.3M in payments to 2,230 healthcare providers, recorded across 4,109 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2017 to 2019. In 2019, $1.1M was paid across 1,848 transactions to 1,131 doctors.
The most common payment nature for DISEASE STATE is "Consulting Fee" ($1.9M, 84.3% of total).